Lipoprotein (a) and the Risk of Chronic Kidney Disease in Hospitalized Japanese Patients

Internal Medicine
Hayato TadaMasa-Aki Kawashiri

Abstract

Objective Lipoprotein (a), or Lp (a), has been shown to be associated with the development of chronic kidney disease (CKD) in populations of various ethnicities. This study aimed to investigate the association between serum Lp (a) and CKD in Japanese patients. Methods A total of 6,130 subjects who underwent a serum Lp (a) level assessment for any reason (e.g. any type of surgery requiring prolonged bed rest or risk factors for atherosclerosis, such as hypertension or diabetes) were retrospectively investigated at Kanazawa University Hospital from April 2004 to March 2014. Of these, 1,895 subjects were excluded because of the lack of clinical data. Subjects were assessed for Lp (a), low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, hypertension, diabetes, smoking, body mass index (BMI), coronary artery disease (CAD), and CKD (stage ≥3). Results When the study subjects were divided into quartiles of Lp (a) levels, significant trends were observed with regard to the presence of CKD (p = 2.7×10-13). A multiple regression analysis showed that Lp (a) was significantly associated with CKD [odds ratio (OR), 1.12; 95% confidence interval (CI), 1.08-1.17; p = 1.3×10-7, per 10 mg/dL], in...Continue Reading

References

Jan 23, 1999·The American Journal of Cardiology·S M Marcovina, M L Koschinsky
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Jan 1, 1963·Acta Pathologica Et Microbiologica Scandinavica·K BERG
Nov 18, 2006·Clinics in Laboratory Medicine·Erdembileg AnuuradLars Berglund
Apr 19, 2007·Kidney International·P E StevensC K T Farmer
Apr 3, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Seiichi MatsuoUNKNOWN Collaborators developing the Japanese equation for estimated GFR
Jul 23, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Aug 16, 2011·Lancet·Andrew S Levey, Josef Coresh
Oct 17, 2013·Clinical and Experimental Nephrology·Florian Kronenberg
Oct 19, 2010·Journal of Diabetes Investigation·Yutaka SeinoKohjiro Ueki
Jul 24, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·J-S YunS-H Ko
Nov 26, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Xinfang XieHaiyan Wang
Nov 4, 2016·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Barbara KolleritsUNKNOWN German Diabetes and Dialysis Study Investigators
Dec 23, 2016·Journal of the American College of Cardiology·Connor A EmdinUNKNOWN CARDIoGRAM Exome Consortium

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay

Software Mentioned

R

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

Current Atherosclerosis Reports
J D Morrisett
Journal of Ayub Medical College, Abbottabad : JAMC
Salma AttaullahJamilur Rehman
Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Christiane Keller
Vnitr̆ní lékar̆ství
L ZlatohlávekM Vrablík
Heart Views : the Official Journal of the Gulf Heart Association
Fauzia AshfaqMohd Zafar Idris
© 2021 Meta ULC. All rights reserved